TY - JOUR
T1 - Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer
AU - Sloth Møller, Ditte
AU - Knap, Marianne Marquard
AU - Nyeng, Tine Bisballe
AU - Khalil, Azza Ahmed
AU - Holt, Marianne Ingerslev
AU - Kandi, Maria
AU - Hoffmann, Lone
PY - 2017/11/2
Y1 - 2017/11/2
N2 - Introduction: Minimizing the planning target volume (PTV) while ensuring sufficient target coverage during the entire respiratory cycle is essential for free-breathing radiotherapy of lung cancer. Different methods are used to incorporate the respiratory motion into the PTV. Material and methods: Fifteen patients were analyzed. Respiration can be included in the target delineation process creating a respiratory GTV, denoted iGTV. Alternatively, the respiratory amplitude (A) can be measured based on the 4D-CT and A can be incorporated in the margin expansion. The GTV expanded by A yielded GTV + resp, which was compared to iGTV in terms of overlap. Three methods for PTV generation were compared. PTV
del (delineated iGTV expanded to CTV plus PTV margin), PTV
σ (GTV expanded to CTV and A was included as a random uncertainty in the CTV to PTV margin) and PTV
∑ (GTV expanded to CTV, succeeded by CTV linear expansion by A to CTV + resp, which was finally expanded to PTV
∑). Results: Deformation of tumor and lymph nodes during respiration resulted in volume changes between the respiratory phases. The overlap between iGTV and GTV + resp showed that on average 7% of iGTV was outside the GTV + resp implying that GTV + resp did not capture the tumor during the full deformable respiration cycle. A comparison of the PTV volumes showed that PTV
σ was smallest and PTV
Σ largest for all patients. PTV
σ was in mean 14% (31 cm
3) smaller than PTV
del, while PTV
del was 7% (20 cm
3) smaller than PTV
Σ. Conclusions: PTV
σ yields the smallest volumes but does not ensure coverage of tumor during the full respiratory motion due to tumor deformation. Incorporating the respiratory motion in the delineation (PTV
del) takes into account the entire respiratory cycle including deformation, but at the cost, however, of larger treatment volumes. PTV
Σ should not be used, since it incorporates the disadvantages of both PTV
del and PTV
σ.
AB - Introduction: Minimizing the planning target volume (PTV) while ensuring sufficient target coverage during the entire respiratory cycle is essential for free-breathing radiotherapy of lung cancer. Different methods are used to incorporate the respiratory motion into the PTV. Material and methods: Fifteen patients were analyzed. Respiration can be included in the target delineation process creating a respiratory GTV, denoted iGTV. Alternatively, the respiratory amplitude (A) can be measured based on the 4D-CT and A can be incorporated in the margin expansion. The GTV expanded by A yielded GTV + resp, which was compared to iGTV in terms of overlap. Three methods for PTV generation were compared. PTV
del (delineated iGTV expanded to CTV plus PTV margin), PTV
σ (GTV expanded to CTV and A was included as a random uncertainty in the CTV to PTV margin) and PTV
∑ (GTV expanded to CTV, succeeded by CTV linear expansion by A to CTV + resp, which was finally expanded to PTV
∑). Results: Deformation of tumor and lymph nodes during respiration resulted in volume changes between the respiratory phases. The overlap between iGTV and GTV + resp showed that on average 7% of iGTV was outside the GTV + resp implying that GTV + resp did not capture the tumor during the full deformable respiration cycle. A comparison of the PTV volumes showed that PTV
σ was smallest and PTV
Σ largest for all patients. PTV
σ was in mean 14% (31 cm
3) smaller than PTV
del, while PTV
del was 7% (20 cm
3) smaller than PTV
Σ. Conclusions: PTV
σ yields the smallest volumes but does not ensure coverage of tumor during the full respiratory motion due to tumor deformation. Incorporating the respiratory motion in the delineation (PTV
del) takes into account the entire respiratory cycle including deformation, but at the cost, however, of larger treatment volumes. PTV
Σ should not be used, since it incorporates the disadvantages of both PTV
del and PTV
σ.
KW - Journal Article
UR - http://www.scopus.com/inward/record.url?scp=85029432659&partnerID=8YFLogxK
U2 - 10.1080/0284186X.2017.1373848
DO - 10.1080/0284186X.2017.1373848
M3 - Journal article
C2 - 28885090
SN - 0284-186X
VL - 56
SP - 1604
EP - 1609
JO - Acta Oncologica
JF - Acta Oncologica
IS - 11
ER -